Cantor Fitzgerald Europe lowers stake in SymBio Pharmaceuticals to 7.35%
Stake history
Summary
Cantor Fitzgerald Europe filed a Change in 5%+ stake (change report) via EDINET on 2026-03-04 14:18 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 7.35%, previous report: 9.26%.